This recurring Special Emphasis Panel reviews applications using basic and clinical approaches to study the ocular surface, cornea, lacrimal and meibomian glands, anterior segment glaucoma, and refractive error of the eye.
The List of Reviewers lists all present, whether standing members or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.
- Basic biological studies of the ocular surface, cornea, lacrimal and meibomian glands
- Diseases and disorders of the ocular surface and cornea, such as allergies, dry eye syndrome, lacrimal and meibomian gland dysfunction, bacterial, fungal, and viral corneal infections, corneal dystrophies, Fuchs' dystrophy, keratoconus, uveal melanoma, etc.
- All aspects of immunology, infection, and inflammation unique to the eye, such as uveitis (anterior and posterior eye segments)
- Corneal development and differentiation
- Corneal wound healing and regeneration, and aspects of corneal transplantation
- Corneal and limbal stem and progenitor cells
- Refractive error of the eye, myopia, hyperopia, presbyopia, etc.
- Anterior eye segment contribution to glaucoma
- Drug delivery to the ocular surface or cornea
Shared Interests and Overlaps
Diseases and Pathophysiology of the Visual System (DPVS) vs ZRG1 BDCN-J (81): All aspects of immunology, infection, and inflammation unique to the eye, such as uveitis are reviewed in ZRG1 BDCN-J (81) vs. aspects of immunology and inflammation associated with AMD, DR, optic neuropathies, etc are reviewed in DPVS. Anterior eye segment contribution to glaucoma reviewed by ZRG1 BDCN-J (81) vs. optic neuropathies, including glaucoma (posterior eye segment) reviewed by DPVS.
Biology of the Visual System (BVS) vs ZRG1 BDCN-J (81): The basic biological studies of the eye with the focus on the fundamental processes and mechanisms, including anterior and posterior aspects of glaucoma, including studies of trabecular meshwork, aqueous outflow, regulation of intraocular pressure, are reviewed by BVS vs. applications where the major focus is on etiology, pathophysiology, prevention, diagnosis, and treatment of diseases and disorders are reviewed in ZRG1 BDCN-J (81). Lens, cataract, and posterior capsule opacification studies are reviewed by BVS.
Bioengineering of Neuroscience, Vision and Low Vision Technologies (BNVT) vs ZRG1 BDCN-J (81): Development of bioengineering approaches, therapeutic formulations and drug delivery strategies for treatment of ocular disorders reviewed by BNVT vs. testing the applicability of these approaches and therapies for the treatment of diseases and disorders of the ocular surface, cornea, lacrimal and meibomian glands reviewed by ZRG1 BDCN-J (81).
Neuroscience and Ophthalmic Imaging Technologies (NOIT) vs ZRG1 BDCN-J (81): Applications focused on the development of imaging methodologies are primarily reviewed by NOIT vs their use for the disorders and diseases of the ocular surface, cornea reviewed by ZRG1 BDCN-J (81).